Virtual Screening Retrospective Validation Rate (VSRVR)

GMI-PH-045Pharmaceutical OperationsResearch-Forward

Definition

Retrospective validation of AI virtual screening, reported as coverage (compounds advanced on AI prediction that were ever checked against assay results) and accuracy (checked predictions falling within tolerance).

The Measurement Gap

A pharmaceutical R&D organization spends $4.2 million annually on an AI virtual screening platform that predicts binding affinity for target proteins. Management tracks hit rate, which rose from 11% to 23% after implementation. The ROI calculation looks strong.

But nobody tracks whether the AI's specific predictions were accurate. When the model predicted pIC50 of 7.8 and actual measurement was 6.1, that discrepancy sits unexamined. The prediction is used to make the synthesis decision, then forgotten. The computational chemist moves to the next target. The prediction and the outcome live in different databases maintained by different teams.

This disconnect creates two problems. First, model accuracy might be degrading over time as the target landscape shifts, with no mechanism to detect it. Hit rate does not reveal calibration because a model predicting pIC50 of 8.0 for every compound will have decent hit rate while being useless for prioritization. Second, the organization has no basis for knowing when to retrain the model, which compound classes are reliable, or which structural families are outside the model's domain of applicability. The team uses every prediction with uniform confidence because no data differentiates reliable predictions from unreliable ones.

Formula

VSRVR_coverage = compounds_with_retrospective_validation / compounds_advanced_on_AI_prediction

VSRVR_accuracy = predictions_within_tolerance / compounds_validated

Tolerance = acceptable prediction error margin, e.g., 1 log unit for pIC50

Worked Example:

Compounds advanced based on AI screening: 342. Compounds with actual binding data generated: 287 (55 failed at synthesis). Compounds where prediction was compared to actual: 43.

VSRVR_coverage = 43/342 = 12.6%. Only 12.6% of AI-driven decisions were retrospectively validated.

Of 43 validated: predictions within 1-log-unit tolerance: 29.
VSRVR_accuracy = 29/43 = 67.4%.

A log unit in pIC50 corresponds to a 10-fold difference in binding affinity. One-third of predictions were off by more than 10x.

Segmenting by compound class: established scaffolds with extensive historical data showed 81.3% accuracy (13/16). Novel scaffolds with limited precedent showed 51.9% accuracy (14/27). The model is significantly more reliable for familiar chemistry and unreliable for the novel scaffolds the organization most wants to pursue.

Proposed formula, pending validation pilots.

At a Glance

Unit
Percentage
Trend Direction
Higher
Reporting Frequency
Per synthesis campaign; annual validation retrospective
Category
Drug Discovery
← Chemical Space Exploration Breadth (CSEB)GxP Deferred Maintenance Risk Index (GDMRI) →

Assess Your Organization

The AI-GPS Assessment evaluates your AI governance maturity and recommends KPIs like this one for your implementation roadmap.

Take the Free AI-GPS Assessment